Inhibitor effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells

Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
British Journal of Pharmacology (Impact Factor: 4.84). 11/2004; 143(3):379-87. DOI: 10.1038/sj.bjp.0705804
Source: PubMed


Extracts of bitter melon, soybean, dokudami and welsh onion by 40% methanol increased the accumulation of rhodamine-123 by Caco-2 cells, suggesting that these extracts inhibited P-glycoprotein (P-gp).
The extract of bitter melon was separated in a tC18 cartridge column and the eluate from 80% acetonitrile most markedly increased the [3H]-daunomycin accumulation by Caco-2 cells.
The inhibitory compounds in the bitter melon fraction were isolated by HPLC with Pegasil C4 and Pegasil ODS columns. The HPLC fraction having the highest activity was analyzed by 1H-NMR and FAB-MS, and the active compound was identified as 1-monopalmitin.
The inhibitory activities of 1-monopalmitin and its related compounds suggested that the inhibition of P-gp activity was not dependent on the degree of unsaturation of fatty acid in the monoglyceride, but on the chain length. It was also suggested that the monoglyceride structure played an important role in the inhibition of P-gp activity.
Monoglycerides could therefore alter the pharmacokinetics of drugs by inhibiting the P-gp-mediated efflux.
British Journal of Pharmacology (2004) 143, 379–387. doi:10.1038/sj.bjp.0705804

Download full-text


Available from: Hiromichi Nagasawa
  • Source
    • "Cucurbitaceae Momordica charantia 1-monopalmitin, a simple monoglyceride with an abundant fatty acid chain Major inhibitor of P-glycoprotein Konishi et al., 2004 "

    Full-text · Dataset · Jan 2014
  • Source
    • "Modulation of the activity of drug-metabolizing enzymes is most pronounced in the phytochemical prevention of chemical-induced tissue damage and carcinogenesis [35, 36]. Membrane transporters are also the targets of phytochemicals, which results in changes in drug absorption and efflux [16, 37, 38]. Owing to the critical role of these enzymes in drug metabolism, the possibility exists that herb and phytochemical supplementation could change the metabolic rate of xenobiotics, including therapeutic drugs. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Andrographolide is the most abundant terpenoid of A. paniculata which is used in the treatment of diabetes. In this study, we investigated the effects of A. paniculata extract (APE) and andrographolide on the expression of drug-metabolizing enzymes in rat liver and determined whether modulation of these enzymes changed the pharmacokinetics of tolbutamide. Rats were intragastrically dosed with 2 g/kg/day APE or 50 mg/kg/day andrographolide for 5 days before a dose of 20 mg/kg tolbutamide was given. APE and andrographolide reduced the AUC0-12 h of tolbutamide by 37% and 18%, respectively, compared with that in controls. The protein and mRNA levels and enzyme activities of CYP2C6/11, CYP1A1/2, and CYP3A1/2 were increased by APE and andrographolide. To evaluate whether APE or andrographolide affected the hypoglycemic action of tolbutamide, high-fat diet-induced obese mice were used and treated in the same manner as the rats. APE and andrographolide increased CYP2C6/11 expression and decreased plasma tolbutamide levels. In a glucose tolerance test, however, the hypoglycemic effect of tolbutamide was not changed by APE or andrographolide. These results suggest that APE and andrographolide accelerate the metabolism rate of tolbutamide through increased expression and activity of drug-metabolizing enzymes. APE and andrographolide, however, do not impair the hypoglycemic effect of tolbutamide.
    Full-text · Article · Aug 2013 · Evidence-based Complementary and Alternative Medicine
  • Source
    • "Cucurbitaceae Momordica charantia 1-monopalmitin, a simple monoglyceride with an abundant fatty acid chain Major inhibitor of P-glycoprotein Konishi et al., 2004 "
    [Show abstract] [Hide abstract]
    ABSTRACT: The use of ethnomedicines to manage HIV/AIDS has recently gained public interest, although harmonization with official HIV/AIDS policy remains a contentious issue in many countries. Plants and other natural products present a large repertoire from which to isolate novel anti-HIV active compounds. In this literature survey, 55 plant families containing 95 plant species, and other natural products, were found to contain anti-HIV active compounds that included diterpenes, triterpenes, biflavonoids, coumarins, caffeic acid tetramers, hypericin, gallotannins, galloylquinic acids, curcumins, michellamines, and limonoids. These active compounds inhibited various steps in the HIV life cycle. However, further studies are needed to determine their interactions with current regimes of antiretroviral drugs. More clinical trials of candidate drugs developed from these novel compounds are also encouraged.
    Full-text · Article · Oct 2010
Show more